Indications are Parkinson’s disease and idiopathic restless legs syndrome
Otsuka Pharma press release, Dec. 25, 2012
Otsuka Pharma obtains registration in Japan for new pro patch”, for percutaneous application of a dopamine receptor agonist “
Indications are Parkinson’s disease and idiopathic restless legs syndrome
Otsuka Pharma press release, Dec. 25, 2012